<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">34993731</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>16</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1573-2576</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>45</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Inflammation</Title>
          <ISOAbbreviation>Inflammation</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Quantile-Dependent Expressivity of Serum Interleukin-6 Concentrations as a Possible Explanation of Gene-Disease Interactions, Gene-Environment Interactions, and Pharmacogenetic Effects.</ArticleTitle>
        <Pagination>
          <StartPage>1059</StartPage>
          <EndPage>1075</EndPage>
          <MedlinePgn>1059-1075</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s10753-021-01601-0</ELocationID>
        <Abstract>
          <AbstractText>Interleukin 6 (IL-6) is a moderately heritable pleiotropic cytokine whose elevated concentrations in coronary artery disease, peripheral arterial disease, pulmonary arterial hypertension, Eales' disease, Sjògren's syndrome, osteoarthritis, adenocarcinoma, neuroblastoma, polymyalgia rheumatica, pulmonary tuberculosis, and enterovirus 71 infection, and following coronary artery bypass graft show larger genetic effects than in unaffected low IL-6 controls. We hypothesize that genetic effects may depend upon whether average IL-6 concentrations are high or low, i.e., quantile-dependent expressivity. Quantile-specific offspring-parent (β<sub>OP</sub>) and full-sib regression slopes (β<sub>FS</sub>) were estimated by applying quantile regression to the age- and sex-adjusted serum IL-6 concentrations in families surveyed in the Framingham Heart Study. Quantile-specific heritabilities were calculated as h<sup>2</sup> = 2β<sub>OP</sub> / (1 + r<sub>spouse</sub>) and h<sup>2</sup> = {(1 + 8r<sub>spouse</sub>β<sub>FS</sub>)<sup>0.5</sup> -1} / (2r<sub>spouse</sub>)). Heritability (h<sup>2</sup> ± SE) of IL-6 concentrations increased from 0.01 ± 0.01 at the 10th percentile (NS), 0.02 ± 0.01 at the 25th (P = 0.009), 0.03 ± 0.01 at the 50th (P = 0.007), 0.04 ± 0.02 at the 75th (P = 0.004), and 0.13 ± 0.05 at the 90th percentile (P = 0.03), or 0.0005 ± 0.0002 for each 1% increase in the offspring's phenotype distribution (P<sub>linear trend</sub> = 0.02) when estimated from β<sub>OP</sub> and from 0.02 ± 0.02 at the 10th (NS), 0.02 ± 0.02 at the 25th (NS), 0.06 ± 0.02 at the 50th (P = 0.01), 0.12 ± 0.04 at the 75th (P = 0.001), and 0.30 ± 0.03 at the 90th percentile (P &lt; 10<sup>-16</sup>), or 0.0015 ± 0.0007 for each 1% increase in the sibling phenotype distribution (P<sub>linear trend</sub> = 0.02) when estimated from β<sub>FS</sub>. Thus the heritability of serum IL-6 concentrations is quantile dependent, which may contribute in part to the larger genetic effect size reported for diseases and environmental conditions that elevate IL-6 concentrations vis-à-vis unaffected controls.</AbstractText>
          <CopyrightInformation>© 2021. This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Williams</LastName>
            <ForeName>Paul T</ForeName>
            <Initials>PT</Initials>
            <Identifier Source="ORCID">0000-0002-4872-4556</Identifier>
            <AffiliationInfo>
              <Affiliation>Lawrence Berkeley National Laboratory, Molecular Biophysics &amp; Integrated Bioimaging Division, 1 Cyclotron Road, Berkeley, CA, 94720, USA. ptwilliams@lbl.gov.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>HHSN268201500001C</GrantID>
            <Acronym>HL</Acronym>
            <Agency>NHLBI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R21 ES020700</GrantID>
            <Acronym>ES</Acronym>
            <Agency>NIEHS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>HHSN268201500001I</GrantID>
            <Acronym>HL</Acronym>
            <Agency>NHLBI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R21ES020700</GrantID>
            <Acronym>ES</Acronym>
            <Agency>NIEHS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>N01HC25195</GrantID>
            <Acronym>HL</Acronym>
            <Agency>NHLBI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Inflammation</MedlineTA>
        <NlmUniqueID>7600105</NlmUniqueID>
        <ISSNLinking>0360-3997</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D015850">Interleukin-6</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D059647" MajorTopicYN="Y">Gene-Environment Interaction</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015850" MajorTopicYN="Y">Interleukin-6</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010597" MajorTopicYN="N">Pharmacogenetics</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">gene-environment interaction</Keyword>
        <Keyword MajorTopicYN="N">heritability</Keyword>
        <Keyword MajorTopicYN="N">inflammation.</Keyword>
        <Keyword MajorTopicYN="N">interleukin-6</Keyword>
        <Keyword MajorTopicYN="N">pharmacogenetics</Keyword>
      </KeywordList>
      <CoiStatement><i>Competing interests</i>. None to report</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>7</Month>
          <Day>26</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2023</Year>
          <Month>6</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>42</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34993731</ArticleId>
        <ArticleId IdType="mid">NIHMS1769859</ArticleId>
        <ArticleId IdType="pmc">PMC9106828</ArticleId>
        <ArticleId IdType="doi">10.1007/s10753-021-01601-0</ArticleId>
        <ArticleId IdType="pii">10.1007/s10753-021-01601-0</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Hirano T
IL-6 in inflammation, autoimmunity and cancer. Int Immunol. 2021;33:127–148. doi: 10.1093/intimm/dxaa078.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/intimm/dxaa078</ArticleId>
            <ArticleId IdType="pmc">PMC7799025</ArticleId>
            <ArticleId IdType="pubmed">33337480</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Terry CF, Loukaci V, Green FR. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem. 2000;275:18138–44. doi: 10.1074/jbc.M000379200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M000379200</ArticleId>
            <ArticleId IdType="pubmed">10747905</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ahluwalia TS, Prins BP, Abdollahi M, Armstrong NJ, Aslibekyan S, Bain L, Jefferis B, Baumert J, Beekman M, Ben-Shlomo Y, Bis JC, Mitchell BD, de Geus E, Delgado GE, Marek D, Eriksson J, Kajantie E, Kanoni S, Kemp JP, Lu C, Marioni RE, McLachlan S, Milaneschi Y, Nolte IM, Petrelis AM, Porcu E, Sabater-Lleal M, Naderi E, Seppälä I, Shah T, Singhal G, Standl M, Teumer A, Thalamuthu A, Thiering E, Trompet S, Ballantyne CM, Benjamin EJ, Casas JP, Toben C, Dedoussis G, Deelen J, Durda P, Engmann J, Feitosa MF, Grallert H, Hammarstedt A, Harris SE, Homuth G, Hottenga JJ, Jalkanen S, Jamshidi Y, Jawahar MC, Jess T, Kivimaki M, Kleber ME, Lahti J, Liu Y, Marques-Vidal P, Mellström D, Mooijaart SP, Müller-Nurasyid M, Penninx B, Revez JA, Rossing P, Räikkönen K, Sattar N, Scharnagl H, Sennblad B, Silveira A, Pourcain BS, Timpson NJ, Trollor J; CHARGE Inflammation Working Group, van Dongen J, Van Heemst D, Visvikis-Siest S, Vollenweider P, Völker U, Waldenberger M, Willemsen G, Zabaneh D, Morris RW, Arnett DK, Baune BT, Boomsma DI, Chang YC, Deary IJ, Deloukas P, Eriksson JG, Evans DM, Ferreira MA, Gaunt T, Gudnason V, Hamsten A, Heinrich J, Hingorani A, Humphries SE, Jukema JW, Koenig W, Kumari M, Kutalik Z, Lawlor DA, Lehtimäki T, März W, Mather KA, Naitza S, Nauck M, Ohlsson C, Price JF, Raitakari O, Rice K, Sachdev PS, Slagboom E, Sørensen TIA, Spector T, Stacey D, Stathopoulou MG, Tanaka T, Wannamethee SG, Whincup P, Rotter JI, Dehghan A, Boerwinkle E, Psaty BM, Snieder H, Alizadeh BZ. Genome-wide association study of circulating interleukin 6 levels identifies novel loci. Hum Mol Genet. 2021;30:393–409. doi: 10.1093/hmg/ddab023.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/hmg/ddab023</ArticleId>
            <ArticleId IdType="pmc">PMC8098112</ArticleId>
            <ArticleId IdType="pubmed">33517400</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grunnet L, Poulsen P, Klarlund Pedersen B, Mandrup-Poulsen T, Vaag A. Plasma cytokine levels in young and elderly twins: genes versus environment and relation to in vivo insulin action. Diabetologia. 2006;49:343–50. doi: 10.1007/s00125-005-0080-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00125-005-0080-8</ArticleId>
            <ArticleId IdType="pubmed">16374628</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Haddy N, Sass C, Maumus S, Marie B, Droesch S, Siest G, Lambert D, Visvikis S. Biological variations, genetic polymorphisms and familial resemblance of TNF-alpha and IL-6 concentrations: STANISLAS cohort. Eur J Hum Genet. 2005;13:109–17. doi: 10.1038/sj.ejhg.5201294.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.ejhg.5201294</ArticleId>
            <ArticleId IdType="pubmed">15523500</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sas AA, Jamshidi Y, Zheng D, Wu T, Korf J, Alizadeh BZ, Spector TD, Snieder H. The age-dependency of genetic and environmental influences on serum cytokine levels: a twin study. Cytokine .
2012;60:108–13. doi: 10.1016/j.cyto.2012.04.047.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cyto.2012.04.047</ArticleId>
            <ArticleId IdType="pubmed">22673037</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>de Maat MP, Bladbjerg EM, Hjelmborg Jv, Bathum L, Jespersen J, Christensen K. Genetic influence on inflammation variables in the elderly. Arterioscler Thromb Vasc Biol .
2004;24:2168–73. doi: 10.1161/01.ATV.0000143856.01669.e7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/01.ATV.0000143856.01669.e7</ArticleId>
            <ArticleId IdType="pubmed">15345506</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Neijts M, van Dongen J, Kluft C, Boomsma DI, Willemsen G, de Geus EJ. Genetic architecture of the pro-inflammatory state in an extended twin-family design. Twin Res Hum Genet .
2013;16:931–40. doi: 10.1017/thg.2013.58.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1017/thg.2013.58</ArticleId>
            <ArticleId IdType="pubmed">23953347</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pantsulaia I, Trofimov S, Kobyliansky E, Livshits G. Genetic and environmental influences on IL-6 and TNF-alpha plasma levels in apparently healthy general population. Cytokine. 2002;19:138–46. doi: 10.1006/cyto.2002.1959.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1006/cyto.2002.1959</ArticleId>
            <ArticleId IdType="pubmed">12242080</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Su S, Snieder H, Miller AH, Ritchie J, Bremner JD, Goldberg J, Dai J, Jones L, Murrah NV, Zhao J, Vaccarino V. Genetic and environmental influences on systemic markers of inflammation in middle-aged male twins. Atherosclerosis. 2008;200:213–20. doi: 10.1016/j.atherosclerosis.2007.12.009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.atherosclerosis.2007.12.009</ArticleId>
            <ArticleId IdType="pmc">PMC2599923</ArticleId>
            <ArticleId IdType="pubmed">18243214</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Prakash J, Williams FM, Trofimov S, Surdulescu G, Spector T, Livshits G. Quantitative genetics of circulating Dickkopf-related protein 1 (DKK1) in community-based sample of UK twins. Osteoporos Int. 2016;27:2065–75. doi: 10.1007/s00198-016-3486-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00198-016-3486-x</ArticleId>
            <ArticleId IdType="pubmed">26762129</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Su S, Miller AH, Snieder H, Bremner JD, Ritchie J, Maisano C, Jones L, Murrah NV, Goldberg J, Vaccarino V. Common genetic contributions to depressive symptoms and inflammatory markers in middle-aged men: the Twins Heart Study. Psychosom Med .
2009;71:152–8. doi: 10.1097/PSY.0b013e31819082ef.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/PSY.0b013e31819082ef</ArticleId>
            <ArticleId IdType="pmc">PMC2904952</ArticleId>
            <ArticleId IdType="pubmed">19073752</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wörns MA, Victor A, Galle PR, Höhler T. Genetic and environmental contributions to plasma C-reactive protein and interleukin-6 levels--a study in twins. Genes Immun. 2006;7:600–5. doi: 10.1038/sj.gene.6364330.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.gene.6364330</ArticleId>
            <ArticleId IdType="pubmed">16900203</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>de Craen AJ, Posthuma D, Remarque EJ, van den Biggelaar AH, Westendorp RG, Boomsma DI. Heritability estimates of innate immunity: an extended twin study. Genes Immun .
2005;6:167–70. doi: 10.1038/sj.gene.6364162.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.gene.6364162</ArticleId>
            <ArticleId IdType="pubmed">15674372</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brull DJ, Montgomery HE, Sanders J, Dhamrait S, Luong L, Rumley A, Lowe GD, Humphries SE. Interleukin-6 gene -174g&gt;c and -572g&gt;c promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arterioscler Thromb Vasc Biol. 2001;21:1458–63. doi: 10.1161/hq0901.094280.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/hq0901.094280</ArticleId>
            <ArticleId IdType="pubmed">11557672</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Libra M, Signorelli SS, Bevelacqua Y, Navolanic PM, Bevelacqua V, Polesel J, Talamini R, Stivala F, Mazzarino MC, Malaponte G. Analysis of G(-174)C IL-6 polymorphism and plasma concentrations of inflammatory markers in patients with type 2 diabetes and peripheral arterial disease. J Clin Pathol. 2006;59:211–5. doi: 10.1136/jcp.2004.025452.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/jcp.2004.025452</ArticleId>
            <ArticleId IdType="pmc">PMC1860309</ArticleId>
            <ArticleId IdType="pubmed">16443741</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sen A, Paine SK, Chowdhury IH, Mukherjee A, Choudhuri S, Saha A, Mandal LK, Bhattacharya B. Impact of interleukin-6 promoter polymorphism and serum interleukin-6 level on the acute inflammation and neovascularization stages of patients with Eales’ disease. Mol Vis. 2011;17:2552–63.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3198485</ArticleId>
            <ArticleId IdType="pubmed">22025890</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Talar-Wojnarowska R, Gasiorowska A, Smolarz B, Romanowicz-Makowska H, Kulig A, Malecka-Panas E. Clinical significance of interleukin-6 (IL-6) gene polymorphism and IL-6 serum level in pancreatic adenocarcinoma and chronic pancreatitis. Dig Dis Sci. 2009;54:683–9. doi: 10.1007/s10620-008-0390-z.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10620-008-0390-z</ArticleId>
            <ArticleId IdType="pubmed">18661238</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang G, Zhou B, Wang W, Zhang M, Zhao Y, Wang Z, Yang L, Zhai J, Feng CG, Wang J, Chen X. A functional single-nucleotide polymorphism in the promoter of the gene encoding interleukin 6 is associated with susceptibility to tuberculosis. J Infect Dis. 2012;205:1697–704. doi: 10.1093/infdis/jis266.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/infdis/jis266</ArticleId>
            <ArticleId IdType="pmc">PMC3415858</ArticleId>
            <ArticleId IdType="pubmed">22457277</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Panayides A, Ioakeimidou A, Karamouzos V, Antonakos N, Koutelidakis I, Giannikopoulos G, Makaritsis K, Voloudakis N, Toutouzas K, Rovina N, Bristianou M, Damoraki G, Routsi C, Giamarellos-Bourboulis EJ; Hellenic Sepsis Study Group. -572 G/C single nucleotide polymorphism of interleukin-6 and sepsis predisposition in chronic renal disease. Eur J Clin Microbiol Infect Dis. 2015;34:2439–46. doi: 10.1007/s10096-015-2500-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10096-015-2500-0</ArticleId>
            <ArticleId IdType="pmc">PMC7102147</ArticleId>
            <ArticleId IdType="pubmed">26463449</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fang M, Huang Y, Zhang Y, Ning Z, Zhu L, Li X. Interleukin-6 -572C/G polymorphism is associated with serum interleukin-6 levels and risk of idiopathic pulmonary arterial hypertension .
J Am Soc Hypertens. 2017;11:171–177. doi: 10.1016/j.jash.2017.01.011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jash.2017.01.011</ArticleId>
            <ArticleId IdType="pubmed">28229900</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yuan A, Li J, Liu P, Chen Z, Hou M, Wang J, Han Z. Association of interleukin-6-572C/G gene polymorphism and serum or cerebrospinal fluid interleukin-6 level with enterovirus 71 encephalitis in Chinese Han patients with hand, foot, and mouth disease. Inflammation. 2015;38:728–35. doi: 10.1007/s10753-014-9983-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10753-014-9983-1</ArticleId>
            <ArticleId IdType="pubmed">25081498</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shin KK, Jang Y, Koh SJ, Chae JS, Kim OY, Park S, Choi D, Shin DJ, Kim HJ, Lee JH. Influence of the IL-6 -572C&gt;G polymorphism on inflammatory markers according to cigarette smoking in Korean healthy men. Cytokine. 2007;39:116–22. doi: 10.1016/j.cyto.2007.06.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cyto.2007.06.005</ArticleId>
            <ArticleId IdType="pubmed">17689974</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Burzotta F, Iacoviello L, Di Castelnuovo A, Glieca F, Luciani N, Zamparelli R, Schiavello R, Donati MB, Maseri A, Possati G, Andreotti F. Relation of the -174 G/C polymorphism of interleukin-6 to interleukin-6 plasma levels and to length of hospitalization after surgical coronary revascularization. Am J Cardiol. 2001;88:1125–8. doi: 10.1016/s0002-9149(01)02046-x. PMID:</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s0002-9149(01)02046-x</ArticleId>
            <ArticleId IdType="pubmed">11703956</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hulkkonen J, Pertovaara M, Antonen J, Pasternack A, Hurme M. Elevated interleukin-6 plasma levels are regulated by the promoter region polymorphism of the IL6 gene in primary Sjögren’s syndrome and correlate with the clinical manifestations of the disease. Rheumatology (Oxford). 2001;40:656–61. doi: 10.1093/rheumatology/40.6.656.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/rheumatology/40.6.656</ArticleId>
            <ArticleId IdType="pubmed">11426023</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eddahibi S, Chaouat A, Tu L, Chouaid C, Weitzenblum E, Housset B, Maitre B, Adnot S. Interleukin-6 gene polymorphism confers susceptibility to pulmonary hypertension in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2006. 
Aug;3(6):475–476. doi: 10.1513/pats.200603-038MS.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1513/pats.200603-038MS</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao Q, Jin M, Zhang DW, Zhao W, Wang XS, Yue ZX, Duan C, Huang C, Ma XL. Serum Interleukin-6 Level and the rs1800795 Polymorphism in its Gene Associated with Neuroblastoma Risk in Chinese Children. Chin Med J (Engl). 2018;131:1075–1078. doi: 10.4103/0366-6999.230719.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4103/0366-6999.230719</ArticleId>
            <ArticleId IdType="pmc">PMC5937316</ArticleId>
            <ArticleId IdType="pubmed">29692379</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Talaat RM, Abdel-Aziz AM, El-Maadawy EA, Abdel-Bary N. CD38 and interleukin 6 gene polymorphism in Egyptians with diffuse large B-cell lymphoma (DLBCL). Immunol Invest. 2015;44:265–78. doi: 10.3109/08820139.2014.989328.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3109/08820139.2014.989328</ArticleId>
            <ArticleId IdType="pubmed">25564959</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wypasek E, Undas A, Sniezek-Maciejewska M, Kapelak B, Plicner D, Stepien E, Sadowski J. The increased plasma C-reactive protein and interleukin-6 levels in patients undergoing coronary artery bypass grafting surgery are associated with the interleukin-6-174G &gt; C gene polymorphism. Ann Clin Biochem. 2010;47:343–9. doi: 10.1258/acb.2010.090305.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1258/acb.2010.090305</ArticleId>
            <ArticleId IdType="pubmed">20592333</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Galimudi RK, Spurthi MK, Padala C, Kumar KG, Mudigonda S, Reddy SG, Aiyengar MT, Sahu SK, Rani SH. Interleukin 6(-174G/C) variant and its circulating levels in coronary artery disease patients and their first degree relatives. Inflammation. 2014;37:314–21. doi: 10.1007/s10753-013-9742-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10753-013-9742-8</ArticleId>
            <ArticleId IdType="pubmed">24072607</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boiardi L, Casali B, Farnetti E, Pipitone N, Nicoli D, Cantini F, Macchioni P, Bajocchi G, Catanoso MG, Pulsatelli L, Consonni D, Salvarani C. Relationship between interleukin 6 promoter polymorphism at position -174, IL-6 serum levels, and the risk of relapse/recurrence in polymyalgia rheumatica. J Rheumatol. 2006;33:703–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16583473</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kilpinen S, Hulkkonen J, Wang XY, Hurme M. The promoter polymorphism of the interleukin-6 gene regulates interleukin-6 production in neonates but not in adults. Eur Cytokine Netw. 2001;12:62–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11282548</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Potaczek DP, Undas A, Celinska-Lowenhoff M, Szczeklik A. Interleukin-6 -174 G/C promoter polymorphism and effects of fenofibrate and simvastatin on inflammatory markers in hypercholesterolemic patients. Blood Coagul Fibrinolysis. 2006;17:35–8. doi: 10.1097/01.mbc.0000198052.65505.00.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/01.mbc.0000198052.65505.00</ArticleId>
            <ArticleId IdType="pubmed">16607077</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sanderson SC, Kumari M, Brunner EJ, Miller MA, Rumley A, Lowe GD, Marmot MG, Humphries SE. Association between IL6 gene variants -174G&gt;C and -572G&gt;C and serum IL-6 levels: interactions with social position in the Whitehall II cohort. Atherosclerosis. 2009;204:459–64. doi: 10.1016/j.atherosclerosis.2008.09.019.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.atherosclerosis.2008.09.019</ArticleId>
            <ArticleId IdType="pubmed">19019369</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mälarstig A, Wallentin L, Siegbahn A. Genetic variation in the interleukin-6 gene in relation to risk and outcomes in acute coronary syndrome. Thromb Res. 2007;119:467–73. doi: 10.1016/j.thromres.2006.05.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.thromres.2006.05.001</ArticleId>
            <ArticleId IdType="pubmed">16782174</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bi D, Chen M, Zhang X, Wang H, Xia L, Shang Q, Li T, Zhu D, Blomgren K, He L, Wang X, Xing Q, Zhu C. The association between sex-related interleukin-6 gene polymorphisms and the risk for cerebral palsy. J Neuroinflammation. 2014;11:100. doi: 10.1186/1742-2094-11-100.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1742-2094-11-100</ArticleId>
            <ArticleId IdType="pmc">PMC4060844</ArticleId>
            <ArticleId IdType="pubmed">24903966</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang X, Ma L, Peng F, Wu Y, Chen Y, Yu L, Lei Z, Zhang C. The endothelial dysfunction in patients with type 2 diabetes mellitus is associated with IL-6 gene promoter polymorphism in Chinese population. Endocrine. 2011;40:124–9. doi: 10.1007/s12020-011-9442-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12020-011-9442-9</ArticleId>
            <ArticleId IdType="pubmed">21424184</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Williams PT. Quantile-specific penetrance of genes affecting lipoproteins, adiposity and height. PLoS One. 2012;7:e28764. doi:10.1371/journal.pone.0028764</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0028764</ArticleId>
            <ArticleId IdType="pmc">PMC3250394</ArticleId>
            <ArticleId IdType="pubmed">22235250</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Williams PT. Gene-environment interactions due to quantile-specific heritability of triglyceride and VLDL concentrations. Scientific Reports
2020;10:4486. doi:10.1038/s41598-020-60965-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41598-020-60965-9</ArticleId>
            <ArticleId IdType="pmc">PMC7066156</ArticleId>
            <ArticleId IdType="pubmed">32161301</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Williams PT. Quantile-dependent expressivity of plasma adiponectin concentrations may explain its sex-specific heritability, gene-environment interactions, and genotype-specific response to postprandial lipemia. PeerJ
2020;8:e10099. doi: 10.7717/peerj.10099</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7717/peerj.10099</ArticleId>
            <ArticleId IdType="pmc">PMC7568478</ArticleId>
            <ArticleId IdType="pubmed">33088620</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Williams PT. Quantile-specific heritability of sibling leptin concentrations and its implications for gene-environment interactions. Sci Rep. 2020;10:22152. doi: 10.1038/s41598-020-79116-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41598-020-79116-1</ArticleId>
            <ArticleId IdType="pmc">PMC7747738</ArticleId>
            <ArticleId IdType="pubmed">33335207</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Williams PT. Quantile-dependent heritability of computed tomography, dual-energy x-ray absorptiometry, anthropometric, and bioelectrical measures of adiposity. Int J Obesity
2020; 44:2101–2112. doi: 10.1038/s41366-020-0636-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41366-020-0636-1</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Williams PT. Quantile-specific heritability of plasminogen activator inhibitor type-1 (PAI-1, aka SERPINE1) and other hemostatic factors. J Thromb Haemost. 2021.  (in press). doi: 10.1111/jth.15468.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/jth.15468</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Williams PT. 2021. Quantile-dependent expressivity of serum C-reactive protein concentrations in family sets. PeerJ
9:e10914 DOI 10.7717/peerj.10914</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7717/peerj.10914</ArticleId>
            <ArticleId IdType="pmc">PMC7894107</ArticleId>
            <ArticleId IdType="pubmed">33628645</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Williams PT. Quantile-Dependent Expressivity and Gene-Lifestyle Interactions Involving High-Density Lipoprotein Cholesterol. Lifestyle Genom. 2021;14(1):1–19. doi: 10.1159/000511421.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000511421</ArticleId>
            <ArticleId IdType="pmc">PMC8116986</ArticleId>
            <ArticleId IdType="pubmed">33296900</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Williams PT. Quantile-specific heritability of total cholesterol and its pharmacogenetic and nutrigenetic implications. Int J Cardiol. 2020:S0167-5273(20)34241-8. doi: 10.1016/j.ijcard.2020.11.070.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijcard.2020.11.070</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Williams PT. Quantile-specific heritability of high-density lipoproteins with implications for precision medicine. J Clin Lipid
2020;14:448–458.e0. doi: 10.1016/j.jacl.2020.05.099</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jacl.2020.05.099</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Koenker R, Hallock KF. Quantile regression. J Economic Perspectives. 2001;15:143–56.</Citation>
        </Reference>
        <Reference>
          <Citation>Kannel WB, Feinleib M, McNamara PM, Garrison RJ, Castelli WP. An investigation of coronary heart disease in families. The Framingham offspring study. Am J Epidemiol. 2006;110:281–90.</Citation>
        </Reference>
        <Reference>
          <Citation>Splansky GL, Corey D, Yang Q, Atwood LD, Cupples LA, Benjamin EJ, et al.
The Third Generation Cohort of the National Heart, Lung, and Blood Institute’s Framingham Heart Study: design, recruitment, and initial examination. Am J Epidemiol. 2007;165:1328–35. doi: 10.1093/aje/kwm021.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/aje/kwm021</ArticleId>
            <ArticleId IdType="pubmed">17372189</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Falconer DS, Mackay TFC. Introduction to Quantitative Genetics (fourth ed.) Longmans Green, Harlow, Essex, UK: 
1996</Citation>
        </Reference>
        <Reference>
          <Citation>Shah T, Zabaneh D, Gaunt T, Swerdlow DI, Shah S, Talmud PJ, Day IN, Whittaker J, Holmes MV, Sofat R, Humphries SE, Kivimaki M, Kumari M, Hingorani AD, Casas JP. Gene-centric analysis identifies variants associated with interleukin-6 levels and shared pathways with other inflammation markers. Circ Cardiovasc Genet. 2013;6:163–70. doi: 10.1161/CIRCGENETICS.112.964254.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/CIRCGENETICS.112.964254</ArticleId>
            <ArticleId IdType="pubmed">23505291</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Karlin S, Cameron EC, Williams PT. Sibling and parent-offspring correlation estimation with variable family size. Proc Natl Acad Sci USA. 1981;78:2664–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC319417</ArticleId>
            <ArticleId IdType="pubmed">6942400</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gould WW. Quantile regression with bootstrapped standard errors. Stata Technical Bulletin. 1992;9:19–21.</Citation>
        </Reference>
        <Reference>
          <Citation>Winer BJ, Brown DR, Michels KM. 1991. 
Statistical principles in experimental design. Third edition. McGraw-Hill; 
New York.</Citation>
        </Reference>
        <Reference>
          <Citation>Yang H, Zhou X, Xu D, Chen G. The IL-6 rs12700386 polymorphism is associated with an increased risk of developing osteoarthritis in the knee in the Chinese Han population: a case-control study .
BMC Med Genet. 2020;21:199. doi: 10.1186/s12881-020-01139-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12881-020-01139-2</ArticleId>
            <ArticleId IdType="pmc">PMC7547410</ArticleId>
            <ArticleId IdType="pubmed">33036557</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wypasek E, Stepien E, Kot M, Plicner D, Kapelak B, Sadowski J, Undas A. Fibrinogen beta-chain-C148T polymorphism is associated with increased fibrinogen, C-reactive protein, and interleukin-6 in patients undergoing coronary artery bypass grafting. Inflammation. 2012;35:429–35. doi: 10.1007/s10753-011-9332-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10753-011-9332-6</ArticleId>
            <ArticleId IdType="pmc">PMC3314811</ArticleId>
            <ArticleId IdType="pubmed">21499712</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Williams PT. Quantile-dependent expressivity of postprandial lipemia. PLoS One. 2020;15:e0229495. doi:10.1371/journal.pone.0229495</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0229495</ArticleId>
            <ArticleId IdType="pmc">PMC7043740</ArticleId>
            <ArticleId IdType="pubmed">32101585</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, Woo P. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest. 1998;102:1369–76. doi: 10.1172/JCI2629.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI2629</ArticleId>
            <ArticleId IdType="pmc">PMC508984</ArticleId>
            <ArticleId IdType="pubmed">9769329</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brevetti G, Silvestro A, Di Giacomo S, Bucur R, Di Donato A, Schiano V, Scopacasa F. Endothelial dysfunction in peripheral arterial disease is related to increase in plasma markers of inflammation and severity of peripheral circulatory impairment but not to classic risk factors and atherosclerotic burden. J Vasc Surg. 2003;38:374–9. doi: 10.1016/s0741-5214(03)00124-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s0741-5214(03)00124-1</ArticleId>
            <ArticleId IdType="pubmed">12891123</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lippitz BE and Harris RA
2016. Cytokine patterns in cancer patients: a review of the correlation between interleukin 6 and prognosis. Oncoimmunology
5:e1093722.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4910721</ArticleId>
            <ArticleId IdType="pubmed">27467926</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gu W, Du DY, Huang J, et al.
Identification of interleukin-6 promoter polymorphisms in the Chinese Han population and their functional significance. Crit Care Med
2008;36:1437–43.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18434913</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Humbert M, Monti G, Brenot F, Sitbon O, Portier A, Grangeot-Keros L, Duroux P, Galanaud P, Simonneau G, Emilie D. Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension. Am J Respir Crit Care Med. 1995;151:1628–31. doi: 10.1164/ajrccm.151.5.7735624.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1164/ajrccm.151.5.7735624</ArticleId>
            <ArticleId IdType="pubmed">7735624</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Soon E, Holmes AM, Treacy CM, Doughty NJ, Southgate L, Machado RD, et al.
Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension. Circulation
2010;122:920–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20713898</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Takač B, Mihaljević S, Glavaš-Obrovac L, Kibel A, Suver-Stević M, Canecki-Varžić S, Samardžija M, Rajkovac I, Kovač D, Štefanić M. Interactions among interleukin-6, C-reactive protein, and interleukin-6 (-174) G/C polymorphism in the pathogenesis of Crohn’s disease and ulcerative colitis. Acta Clin Croat. 2020;59:67–80. doi: 10.20471/acc.2020.59.01.09.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.20471/acc.2020.59.01.09</ArticleId>
            <ArticleId IdType="pmc">PMC7382872</ArticleId>
            <ArticleId IdType="pubmed">32724277</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wielińska J, Dratwa M, Świerkot J, Korman L, Iwaszko M, Wysoczańska B, Bogunia-Kubik K. Interleukin 6 gene polymorphism is associated with protein serum level and disease activity in Polish patients with rheumatoid arthritis. HLA. 2018;92
Suppl 2:38–41. doi: 10.1111/tan.13355.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/tan.13355</ArticleId>
            <ArticleId IdType="pubmed">30054992</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
